Publications

• Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
  Dunleavy, K., Pittaluga, S., Maeda, L. S., Advani, R., Chen, C. C., & Wilson, W. H. (2013). Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma. NEW ENGLAND JOURNAL OF MEDICINE, 368(15), 1408-1416.
• A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma
  Warsch, S., Hosein, P. J., Maeda, L. S., Alizadeh, A. A., & Lossos, I. S. (2012). A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma. LEUKEMIA & LYMPHOMA, 53(7), 1299-1305.
• Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
  Nair, V. S., Maeda, L. S., & Ioannidis, J. Pa. (2012). Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(7), 528-540.
• STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., & Horning, S. J. (2011). STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1374-1379.
  
• Current concepts and controversies in the management of early stage Hodgkin lymphoma Maeda, L. S., Lee, M., & Advani, R. H. (2011). Current concepts and controversies in the management of early stage Hodgkin lymphoma. LEUKEMIA & LYMPHOMA, 52(6), 962-971.
  
• The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma Maeda, L. S., & Advani, R. H. (2009). The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma. CURRENT OPINION IN ONCOLOGY, 21(5), 397-400.
  
• Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., & Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902-3907.
  
• Transcription arrest at an abasic site in the transcribed strand of template DNA Tornaletti, S., Maeda, L. S., & Hanawalt, P. C. (2006). Transcription arrest at an abasic site in the transcribed strand of template DNA. CHEMICAL RESEARCH IN TOXICOLOGY, 19(9), 1215-1220.
  
• Transcriptional inhibition by an oxidized abasic site in DNA Wang, Y. L., Sheppard, T. L., Tornaletti, S., Maeda, L. S., & Hanawalt, P. C. (2006). Transcriptional inhibition by an oxidized abasic site in DNA. CHEMICAL RESEARCH IN TOXICOLOGY, 19(2), 234-241.
  
• Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II Silvia, T. A., Maeda, L. S., Kolodner, R. D., & Hanawalt, P. C. (2004). Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. DNA REPAIR, 3(5), 483-494.
  
• Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II Tornaletti, S., Maeda, L. S., Lloyd, D. R., Reines, D., & Hanawalt, P. C. (2001). Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(48), 45367-45371.